Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 16

PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer

Total article views   HTML views PDF downloads Totals
2,350 Dovepress* 2,160+ 60 2,220
PubMed Central* 190 68 258
Totals 2,350 128 2,478
*Since 9 August 2023
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar